Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Thoracic: later-stage trial registry

4 of 6 indexed Thoracic trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Thoracic: 6 US clinical trials tracked, 4 recruiting.

Thoracic is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Intuitive Surgical, running 2 of these trials.

Enrollment posture brief

Registry condition thoracic

OPEN 4 | RECR 67% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Thoracic (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Thoracic

Thoracic lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thoracic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thoracic is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Thoracic research.

    Intuitive Surgical accounts for 2 of 6 trials (33.3%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Thoracic enrolment sits around 120 participants.

    Median target enrolment is 120 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Thoracic splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Thoracic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bupivacaine, 0.5% Drug
1 trials
Bupivacaine, 0.25% Drug
1 trials
Auricular Acupressure Other
1 trials
Prehabilitation Program (Apple Watch Series 6 with exercise flipbook) Device
1 trials
observational study Other
1 trials
Symptom monitoring Other
1 trials
Liposomal Bupivacaine Drug
1 trials

US sites by state

Facility locations filed on Thoracic trials. A trial with sites in several states counts in each.

Illinois 3 trials
Ohio 2 trials
Utah 1 trials
Texas 1 trials
New York 1 trials
North Carolina 1 trials
Louisiana 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thoracic page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thoracic condition card totals 6 registered trials; most-linked intervention Bupivacaine, 0.5%; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.